ダイトの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2025/08/21 | 1,269 | 1,281 | 1,263 | 1,270 | +1 | +0.1% | 40,400 |
2025/08/20 | 1,278 | 1,285 | 1,269 | 1,269 | -17 | -1.3% | 39,300 |
2025/08/19 | 1,281 | 1,292 | 1,277 | 1,286 | +5 | +0.4% | 30,100 |
2025/08/18 | 1,280 | 1,311 | 1,273 | 1,281 | +8 | +0.6% | 83,300 |
2025/08/15 | 1,268 | 1,279 | 1,254 | 1,273 | +5 | +0.4% | 52,700 |
2025/08/14 | 1,250 | 1,272 | 1,250 | 1,268 | +14 | +1.1% | 51,200 |
2025/08/13 | 1,244 | 1,256 | 1,243 | 1,254 | +11 | +0.9% | 41,700 |
2025/08/12 | 1,250 | 1,258 | 1,237 | 1,243 | ±0 | ±0% | 63,100 |
2025/08/08 | 1,235 | 1,247 | 1,219 | 1,243 | +13 | +1.1% | 62,100 |
2025/08/07 | 1,224 | 1,244 | 1,221 | 1,230 | +6 | +0.5% | 78,600 |
2025/08/06 | 1,220 | 1,229 | 1,216 | 1,224 | +9 | +0.7% | 37,000 |
2025/08/05 | 1,213 | 1,223 | 1,205 | 1,215 | +2 | +0.2% | 48,900 |
2025/08/04 | 1,200 | 1,214 | 1,196 | 1,213 | ±0 | ±0% | 57,100 |
2025/08/01 | 1,218 | 1,225 | 1,207 | 1,213 | +4 | +0.3% | 59,600 |
2025/07/31 | 1,199 | 1,222 | 1,196 | 1,209 | +13 | +1.1% | 97,500 |
2025/07/30 | 1,186 | 1,214 | 1,186 | 1,196 | +10 | +0.8% | 177,400 |
2025/07/29 | 1,185 | 1,194 | 1,180 | 1,186 | ±0 | ±0% | 122,000 |
2025/07/28 | 1,194 | 1,200 | 1,184 | 1,186 | -13 | -1.1% | 77,600 |
2025/07/25 | 1,161 | 1,199 | 1,160 | 1,199 | +38 | +3.3% | 102,900 |
2025/07/24 | 1,149 | 1,174 | 1,149 | 1,161 | +11 | +1% | 71,300 |
2025/07/23 | 1,151 | 1,160 | 1,145 | 1,150 | -1 | -0.1% | 83,000 |
2025/07/22 | 1,142 | 1,178 | 1,140 | 1,151 | +5 | +0.4% | 108,300 |
2025/07/18 | 1,155 | 1,160 | 1,138 | 1,146 | -4 | -0.3% | 68,600 |
2025/07/17 | 1,143 | 1,157 | 1,142 | 1,150 | +6 | +0.5% | 76,600 |
2025/07/16 | 1,159 | 1,179 | 1,138 | 1,144 | -6 | -0.5% | 121,900 |
2025/07/15 | 1,142 | 1,162 | 1,128 | 1,150 | +10 | +0.9% | 189,700 |
2025/07/14 | 1,125 | 1,151 | 1,101 | 1,140 | +104 | +10% | 550,000 |
2025/07/11 | 1,030 | 1,054 | 1,028 | 1,036 | +14 | +1.4% | 118,900 |
2025/07/10 | 1,032 | 1,032 | 1,010 | 1,022 | -4 | -0.4% | 71,300 |
2025/07/09 | 1,020 | 1,044 | 1,020 | 1,026 | +11 | +1.1% | 75,200 |
2025/07/08 | 1,015 | 1,021 | 1,010 | 1,015 | ±0 | ±0% | 49,800 |
2025/07/07 | 1,014 | 1,027 | 1,008 | 1,015 | +1 | +0.1% | 56,900 |
2025/07/04 | 1,012 | 1,014 | 1,007 | 1,014 | +2 | +0.2% | 38,500 |
2025/07/03 | 1,004 | 1,017 | 1,000 | 1,012 | +12 | +1.2% | 52,700 |
2025/07/02 | 992 | 1,009 | 989 | 1,000 | +8 | +0.8% | 57,900 |
2025/07/01 | 1,000 | 1,001 | 990 | 992 | -5 | -0.5% | 56,400 |
2025/06/30 | 995 | 1,005 | 990 | 997 | +7 | +0.7% | 79,200 |
2025/06/27 | 990 | 996 | 989 | 990 | +4 | +0.4% | 64,700 |
2025/06/26 | 986 | 988 | 982 | 986 | ±0 | ±0% | 51,400 |
2025/06/25 | 986 | 988 | 983 | 986 | ±0 | ±0% | 44,600 |
2025/06/24 | 1,009 | 1,009 | 984 | 986 | -9 | -0.9% | 52,900 |
2025/06/23 | 995 | 1,006 | 986 | 995 | -11 | -1.1% | 56,600 |
2025/06/20 | 1,000 | 1,016 | 991 | 1,006 | +1 | +0.1% | 259,800 |
2025/06/19 | 1,016 | 1,019 | 1,001 | 1,005 | -10 | -1% | 41,500 |
2025/06/18 | 1,030 | 1,041 | 1,007 | 1,015 | -12 | -1.2% | 43,700 |
2025/06/17 | 1,042 | 1,045 | 1,022 | 1,027 | -20 | -1.9% | 61,200 |
2025/06/16 | 1,051 | 1,051 | 1,038 | 1,047 | +4 | +0.4% | 40,200 |
2025/06/13 | 1,052 | 1,058 | 1,030 | 1,043 | -11 | -1% | 84,600 |
2025/06/12 | 1,065 | 1,065 | 1,048 | 1,054 | -6 | -0.6% | 42,700 |
2025/06/11 | 1,051 | 1,065 | 1,051 | 1,060 | +10 | +1% | 63,800 |
1~
50
件表示中 / 3773件
類似銘柄と比較する
現在ご覧いただいている「ダイト」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ダイト | 127,000円 | +3.7% | +10.9% | 3.15% | 16.56倍 | 0.73倍 |
|
医薬品の原薬製造販売や、製剤の製造受託が主力。ジェネリック(後発医薬品)メーカー向け強い |
クオリプス | 723,000円 | +237.1% | - | 0.00% | - | 10.78倍 |
|
大阪大学発ベンチャー。iPS細胞由来のシートによる世界初の重症心不全治療法開発に注力 |
タウンズ | 57,300円 | +11.5% | -0.9% | 4.89% | 6.86倍 | 3.39倍 |
|
院内で行う迅速抗原検査の体外診断薬専業大手。新型コロナ、インフルなど呼吸器感染症首位 |
生化学 | 67,000円 | -9.6% | -30.2% | 4.48% | 27.10倍 | 0.50倍 |
|
複合糖質で独自性。開発は関節疾患関連に特化。2種のヒアルロン酸製剤は科研と参天が販売 |
富士製薬 | 146,700円 | +15.7% | +5.3% | 3.10% | 10.61倍 | 0.78倍 |
|
女性医療、急性期医療の2領域に強い後発薬メーカー。注射剤が主体。新薬・バイオ後続品も |
市場注目の銘柄
チャート関連のコラム